Table 1 Characteristics of patients with FIGO stage IIIC1 (2018).
Characteristics | No. (100%) |
|---|---|
Total | 325 |
Age (years old) | |
Median | 50 |
<30 | 5 (1.6%) |
30–39 | 26 (8.0%) |
40–49 | 131 (40.3%) |
50–59 | 118 (36.3%) |
60–69 | 39 (12%) |
≥70 | 6 (1.8%) |
Histology | |
Scc | 301 (92.6%) |
non-Scc | 21 (6.5%) |
unclear | 3 (0.9%) |
Tumor size | |
<4 cm | 80 (24.6%) |
≥4 cm | 240 (73.9%) |
unclear | 5 (1.5%) |
Parametrial infiltration | |
yes | 265 (81.5%) |
No | 60 (18.5%) |
Invasion of pelvic wall | |
yes | 60 (18.5%) |
No | 265 (81.5%) |
Invasion of the lower third of vagina | |
Yes | 11 (3.4%) |
No | 314 (96.6%) |
Pelvic lymph node metastasis | |
bilateral | 145 (44.6%) |
unilateral | 135 (41.5%) |
uncertainty | 45 (13.9%) |
Common iliac lymph node metastasis | |
yes | 49 (15.1%) |
no | 231 (71.1%) |
uncertainty | 45 (13.8%) |
Number of PLNM | |
≥2 | 171 (52.6%) |
<2 | 109 (33.5%) |
uncertainty | 45 (13.9%) |
CCT | |
yes | 288 (88.6%) |
no | 37 (11.4%) |
